COMPOSITIONS ET METHODES DE PREVENTION OU DE TRAITEMENT DE MALADIES, D'AFFECTIONS OU DE PROCESSUS CARACTERISES PAR UNE PROLIFERATION ABERRANTE DES FIBROBLASTES ET UN DEPOT DE MATRICE EXTRACELLULAIRE
A pharmaceutical composition for use in the treatment of a disease, condition,orpathologic process characterized by aberrant fibroblast proliferation andextracellularmatrix deposition in a tissue of a subject, wherein the pharmaceuticalcompositioncomprises a therapeutic amount of a polypeptide of the amino acid sequenceYARAAARQARAKALARQLGVAA (SEQ ID NO: 1) or a functional equivalent thereof,and a pharmaceutically acceptable carrier thereof, and wherein the therapeuticamount iseffective to reduce the fibroblast proliferation and extracellular matrixdeposition in thetissue of the subject.
